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Abstract
Healing of the bone fracture is a biological process that is based on various cell lineages 
recruited, activated and regulated by molecular mediators, namely chemokines, growth 
factors, and cytokines, cooperating in a cascade of events aimed to fill the fracture gap 
with callus. Remodeling of the callus rebuilds the microarchitecture to the mature bone—
cancellous or compact, depending on the type of the bone that was primarily at the frac-
ture gap. Restitution of the bone continuity requires activation of mesenchymal stem cells 
that transform into osteoblasts and mature into osteocytes. It is activated and regulated 
by molecules released from blood platelets from posttraumatic hematoma, traumatized 
tissues, nerve endings, and inflowing inflammatory cells. The significance of the inflam-
matory cells in this process is inappreciable, as they eradicate pathogens, remove wound 
debris, and supply the fracture gap with molecules regulating forthcoming cellular 
events. They also provide immune regulation of the healing. To proceed uneventfully, 
healing requires an adequate bone contact and biomechanical environment, proper oxy-
genation, and nutrition. Unfortunately, up to 15% of bone fractures show some kinds of 
disturbances that may result in cessation of reparative processes leading to non-union. 
Factors, responsible for that, are brought to date based on current literature and clinical 
observations.
Keywords: fracture repair, bone fracture, non-union, mechanical, infection, iatrogenic, 
mesenchymal stem cells (MSCs), immune control, pharmaceuticals, nutrition
1. Background
Healing of the bone fracture is a biological process that restores its continuity, mechanical 
properties, and structure. It bases on various cell lineages recruited, activated and regulated 
by molecular mediators, namely chemokines, growth factors, and cytokines, cooperating in a 
cascade of events aimed to fill the fracture gap with callus, which later on is remodeled into 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
mature bone. Thus, this process is, in fact, a regeneration, not healing, as its goal is to restore 
not only the bone’s continuity but also its structure.
Clinically, healing manifests with remission of pain corresponding with gradually increas-
ing stiffness enabling transduction of mechanical loads. Radiographically-with formation and 
remodeling of the callus in-between its gap. Monitoring of this process indicates the advance 
of the reparative processes.
2. Cellular aspects of fracture healing
From the histological point of view, restitution of the bone continuity proceeds due to accu-
mulation and activation of mesenchymal stem cells (MSCs) that, transforming into osteoblasts 
and maturating into osteocytes, synthesize and release proteins forming the extracellular 
matrix (ECM).
In the vast majority of cases, MSCs that settle hematoma differentiate into chondrocytes. But 
revascularization, due to the ingrowth of blood vessels from the vasculature of the adjacent tis-
sues, improves local oxygenation enabling the transformation of newly inflowing progenitors 
into osteoblasts that, maturating into osteocytes, initiate ossification forming bone cuff around the 
fracture gap. Starting from its periphery, it moves toward the center replacing the soft callus with 
woven bone [1, 2]. Later on, it’s remodeling rebuilds the microarchitecture to the mature bone-
cancellous or compact, depending on the type of the bone that was primarily at the fracture gap.
The described above process, the endochondral ossification, proceeds in ca. 97–98% of all frac-
tures, whereas remaining 2–3% heal due to the direct osteonal growth in the process called 
primary bone healing basing on the intramembranous ossification [3]. The latter one is pos-
sible, when the volume of the fracture’s gap is minimal, thus in non-displaced or impacted 
fractures only. In those cases, the short distance between bone fragments enables osteonal 
remodeling toward the fracture gap restoring its vascularization and mineralizing it.
MSCs residue several tissues, including bone marrow, endosteum, and periosteum. They are 
abundantly represented in adipose tissue surrounding the extremity with subcutaneous fat 
and form a subpopulation of its leukocytes in peripheral blood as well [4]. Thus, extravasated 
into posttraumatic hematoma and recruited from adjacent tissues they form a population of 
precursors for reparative processes.
Their accumulation proceeds due to chemotactic stimulation. Stromal-derived factor-1 (SDF-
1; also known as CXC-motif chemokine 12: CXCL12) is one of the most potent attractants of 
MSCs. Widely distributed in bone marrow, it splits in-between neighboring tissues, when 
bone continuity is broken, recruiting progenitors that accumulate at the sites of its highest 
concentration, the fracture gap. Inflowing cells multiply under the mitogenic stimulation of 
platelet-derived growth factor (PDGF) [5].
MSCs are precursors of various cells of mesenchymal origin, including chondrocytes, fibro-
blasts, adipocytes, neurons, and myocytes. The direction of their differentiation depends upon 
molecular regulation and local physicochemical conditions. When stimulated improperly or 
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under unfavorable conditions, they may differentiate into, unwanted from the point of view 
of the fracture healing, cellular population forming cartilaginous or fibrous pseudoarthrosis.
Hypoxia, hypercapnia, and acidosis that characterize deprived of vasculature posttraumatic 
hematoma, promote their differentiation into chondrocytes, whereas higher oxygen tension 
and reduced acidosis-into osteoblasts [6].
3. Molecular stimulators of fracture repair
Four sources of molecular stimulators and regulators of bone healing could be distinguished:
1. Extravagated blood forming the posttraumatic hematoma
2. Traumatized bone and tissues neighboring it
3. Nerve endings at the adjacent tissues
4. Inflowing inflammatory cells
Platelets are the abundant source of molecular substances of blood origin. Released from 
granules into a posttraumatic hematoma, those substances activate, together with mediators 
released from nerve endings, and cellular events proceeding in the fracture gap.
Platelets participate in various reparative processes, being involved in the restoration of trau-
matized mucous and epithelia, healing various soft tissues (i.e. muscle) and the bone, and 
restoration of the vascularity in the process of angiogenesis. An influence of other hematoma 
products, including fibrin clot and activated clotting factors, hemoglobin, complement cas-
cade and subcellular structures such as subcellular fragments of blood cells increases, giving 
an insight into a complex role of several hematoma compounds in the healing [7].
Traumatized tissues provide molecular stimuli that are released in response to injury. Damage 
- associated molecular pattern molecules (DAMPs) are the most potent activators of the sterile, 
traumatic inflammation (“first hit”), whereas the later one (“second hit”) mostly dependents 
on molecules provided by the inflowing immune cells. Those molecules activate immune 
system directly through toll-like receptors (TLRs) [8]. So far, several DAMPs have been distin-
guished, including heat-shock proteins (HSPs), high-mobility group box 1 (HMGB-1), mono-
sodium urate, heparan sulfate, adenosine triphosphate (ATP), polysaccharides, proteoglycan, 
phospholipids, and deoxyribonucleic acid (DNA). Similar capabilities possess hyaluronian 
fragments released from disintegrated ECM [9, 10].
Nerve endings provide neuromediators that participate in fracture repair, including calcitonin 
gene - related peptide and neuropeptide-Y [11]. Released in response to mechanical (injury) 
and physicochemical (hypoxia, acidosis) stimuli, they participate in the molecular regulation 
of cellular events during the reparative phase and callus mineralization [12]. However, they 
were also found to control remodeling [13].
The later abundant source of molecular stimulators are leukocytes originating from the blood-
forming hematoma and inflowing from the peripheral circulation. Granulocytes are the first 
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Figure 1. Schematic representation of recruitment, proliferation, multiplication, and differentiation of MSCs into 
osteoblasts or chondroblasts.
cellular population that actively populates the fracture gap. Those cells infiltrate the wound 
as early as at the sixth hour after injury providing its innate immune protection against patho-
gens, but also participating in reparative processes [14]. Being followed by lymphocytes and 
monocytes/macrophages they form an inflammatory phase of the healing cascade.
The significance of the inflammatory cells for the reparative processes is inappreciable, as 
they eradicate pathogens, remove wound debris and, partially, foreign bodies, but also sup-
ply the fracture gap with molecules regulating forthcoming cellular events. They also provide 
immune regulation of the healing, as the response of the lymph node draining the fracture 
gap was shown to reflect its cellular and molecular processes [35]. This mechanism seems to 
depend on regulatory B and T lymphocytes (B
regs
 and T
regs
), as they were shown to participate 
in fracture healing. B
regs
 were presented to suppress the inflammatory phase secreting anti-
inflammatory cytokines IL-10 (interleukin-10) and TGF-β (transforming growth factor-β), 
and enhancing maturation of T
regs
 [15]. At the early phase of the reparative processes, they 
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probably prevent from auto aggression against infiltrating progenitors, thus enabling them 
to proliferate and differentiate into bone forming cells. Depletion of B
reg
 cells, analogically 
to splenectomy, results in the delay of the fracture healing [16, 17]. Moreover, T cells were 
shown to promote maturation of the osteoblasts [18].
Immune cells are an ample source of several molecular substances, including cytokines (i.e. IL-6 
and IL-8) and growth factors (PDGF, fibroblast growth factor; FGF, TGF-β, and bone morpho-
genetic proteins—BMPs) [19]. Together with molecules released from nerve endings and bone 
marrow, they regulate cellular events stimulating proliferation and differentiation of MSCs.
The most effective MSCs stimulators are the granulocyte colony-stimulating factor (G-CSF) and 
granulocyte-macrophage-colony-stimulating factor (GM-CSF), cytokines (IL-1, IL-3, IL-7, IL-8, 
and IL-12), stem cell factor (SCF), Flt3 (fms like tyrosine kinase 3) ligand, macrophage inflamma-
tory protein-1 (MIP-1) and the chemokines GROβ (growth-regulated oncogene β; also known as 
CXC-2) and SDF-1 [20, 21]. Each of them evokes the unique effect promoting migration, division, 
activating synthesis, and release of molecules forming an appropriate environment or fulfilling 
the specialized biological function. They enable migration, multiplication, and differentiation of 
progenitors into desired cell lineage. The most potent stimulators of MSCs differentiation into, 
according to the local physicochemical environment, chondrocytes, or osteoblasts are TGF-β, 
several BMPs (2, 4, 6, 7, 13, and 14), IGF-1 (insulin-like growth factor), and FGF [22, 23]. The final 
outcome in the form of fracture healing results from the convergent actions of numerous factors 
influencing the target cells in an appropriate time sequence and place (Figure 1).
4. Extracellular matrix mineralization
Mineralization of the ECM restores mechanical properties of the gap bringing back its ability 
to carry body weight. Briefly, it consists in the deposition of calcium and phosphate precipi-
tates, hydroxyapatite, around the mesh of ECM proteins, namely collagens [24]. The process 
takes place in matrix vesicles; subcellular structures of approx. 20–200 nm in diameter that 
contains a number of compounds, including annexins (annexin V), alkaline phosphatase, cal-
bindin-D9k, pyrophosphatases, carbonic anhydrase, AMP-ases, bone sialoprotein-1 (BSP-1), 
osteonectin, osteocalcin, and several growth factors [25].
Matrix vesicles concentrate inorganic substrates for mineralization due to annexin-formed cal-
cium channels and Na/Pi phosphate transporters (NPT3/Pit1; natrium-phosphate transporter 
3/POU domain class 1 transcription factor 1). High concentration of those ions results in their 
spontaneous precipitation to amorphous octa-Ca/Pi crystals that later on, when released from 
the vesicles, are converted by osteonectin, osteocalcin, and bone sialoprotein-1 (BSP-1) into 
hydroxyapatite. Hydroxyapatite crystals are deposited into the ECM at the outer and inner sur-
face of the collagen fibrils [26]. In consequence, the collagen forming ECM being responsible for 
bone elasticity also serves as a scaffold for inorganic substances [27]. Their remodeling by matrix 
metalloproteinases sets the direction of trabecular bone remodeling, creating it is three-dimen-
sional structure according to the direction of mechanical loads, and thus optimizing its micro-
architecture for the most effective resistance [28, 29]. Finally, remodeling restores the structure 
of the primary callus to the mature bone identical to that primarily present at the fracture gap.
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5. Remodeling
Remodeling proceeds in consequence of osteolysis and forthcoming osteogenesis. In the 
beginning, a group of activated osteoclasts, acidifying ECM, dissolve the osteoid and enzy-
matically (MMPs) digest its proteins. In consequence, resorptive (Howship) lacuna is formed.
Released molecules that are stored in the latent form bound to ECM heparan sulfate (BMPs, 
Vascular endothelial growth factor (VEGF), FGF, and EGF) activate proliferation and folding 
into three-dimensional structures of endothelial cells originating from neighboring blood ves-
sels [30]. Those form vascular loops (sprouts) in-growing into the lacunae, providing its blood 
supply. Inflowing MSCs differentiate into osteoblasts that repopulate lacunae as osteocytes 
excreting ECM proteins and mineralizing them.
Osteoclasts at the top (cutting cone) gradually move across the bone as far as they reach its bor-
derline (osteoclastic tunneling; remaining as Haversian canal), and finally undergo apoptosis. 
Passing across the fracture, they restore bone continuity (osteonal fracture healing), but only 
when the distance between bone fragments does not exceed 1 mm [31]. If the distance is higher, 
each bone fragment is remodeled alone and the fracture gap remains intact, that is not healed.
6. Uneventful and disturbed fracture healing
From the clinical point of view, the fracture is considered to be healed, when its mechanical 
properties are restored allowing carrying the body weight. Thus, the main indicators of suc-
cessful healing are lack of the pathological mobility corresponding with a resolution of pain 
and restored the ability to carry mechanical loads confirmed by radiographic images showing 
callus mineralization and remodeling.
It was estimated that up to 15% of fractures display some kind of healing disturbances [32]. 
Depending on the severity of the pathological changes, it ranges from slow fracture healing 
(slow union), delayed union or non-union, if complete inhibition of the reparative processes 
occurs. The lack of union and the resultant non-union (pseudoarthrosis) are diagnosed when 
callus was not formed in-between bone fragments in an assumed period of time and all regen-
erative processes have stopped.
According to the recommendations of the food and drug administration, a non-union could 
be diagnosed, when the fracture is not healed in the 9th post-injury month, or any evidence 
of the healing progress could be observed on X-rays during the three consecutive months. 
However, the number of orthopedists that diagnose non-union as early as at the 6th post-frac-
ture month implementing procedures that improve reparative processes increases. However, 
it is also believed that the time of the healing of a given bone should be determined arbitrarily, 
based on the clinical experience [33].
The varying opinions that concern the definition of disturbed fracture healing come from the lack 
of diagnostic tools that could demonstrate the moment of cessation of regenerative processes. The 
very important flaw of radiographic monitoring is the possibility to assess the status of the healing 
after a sufficiently long period of follow-up. Moreover, it does not allow predicting the final result.
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The only examination that may be useful in the monitoring of the healing process and pre-
dicting its outcome is limb lymphoscintigraphy [34]. Observation of the lymphatic system 
showed that regional lymph node draining the fracture is a subject of molecules released from 
its gap. Thus, increased lymph drainage and enlargement of the lymph node (accumulation 
of cells) reflect molecular and cellular events taking place at the fracture gap that may be used 
as an indicator of the quality of reparative processes (Figure 2).
Uneventful healing may be divided into three phases:
1. Reactive- colonization of posttraumatic hematoma by inflammatory cells,
2. Reparative-replacement of hematoma with cartilaginous tissue and its endochondral os-
sification (primary callus),
3. Remodeling-formation of mature bone with the structure analogous to that prior to the 
fracture.
The first phase lasts up to several (3–7) days, the second up to 4 weeks and the third may 
last up to 2 (or even more) years after the fracture. However, the advance of the healing may 
differ even in adjacent areas; especially, when proceeds in comminuted fractures. In conse-
quence, remodeling already proceeding in between some bone fragments may coexist with 
early, reactive phase between others.
Figure 2. Lymphoscintigrams of the uneventful (left) and disturbed (right) healings of the fractures of the right 
extremities. Uneventful healing is characterized by enlarged regional lymph nodes and lymphatic outflow, when 
compared with contralateral limb. If the healing is disturbed, decreased lymph outflow, and regional lymph nodes, are 
observed.
Fracture Repair: Its Pathomechanism and Disturbances
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Histologically, uneventful healing is characterized by soft callus filling the fracture gap in the 
2nd week after injury (soft callus). In the 4th week, the callus should already be replaced by 
spongy bone (hard callus), and in the 8th-be a subject of remodeling. Non-union is character-
ized by the lack of ossification at the 4th post-fracture week, despite the fact that similarly 
to uneventful healing, the fracture’s gap is filled with an excess of cartilage “flowing” out of 
it. In the 8th week, young fibrous tissue with scarce and loose foci of cartilaginous tissue is 
observed and finally, the pseudoarthrosis is formed [35].
On a molecular level, there are no differences in the expression of PDGF, TGF-β, and FGF-2 in 
the 1st week after the fracture in both uneventfully and healing with delay fracture gaps. But 
in the 8th week, in contrary to uneventful healing, whose osteocytes express all these factors, 
none of them is expressed [36]. It was proved that lack of the mentioned above molecular 
stimuli leading to non-union could also be produced surgically removing tissues from the 
fracture gap that may result from repeated debridement or rinsing drainage [37].
7. Factors disturbing healing of the fracture
As the goal of reparative events is to fill the fracture gap with cells possessing osteogenic 
potential, the participation of their precursors, the MSCs, is crucial. As MSCs are widely dis-
tributed in the body, the risk of their deficiency is rather not feasible. Nevertheless, those cells 
exert some specific features that may reduce their number and activity.
First of all, they are very sensitive to unfavorable conditions, distinctly responding to inordi-
nate mechanical stimuli, hypoxia, and malnutrition [38]. They are also very prone to injury, 
regardless of its mechanism: mechanical, thermal (burns, frostbites), chemical (acids, bases, 
toxins), electric, or radiative. Thus, massive traumatization of tissues neighboring the fracture 
deprives them of progenitors resulting in cessation of reparative processes. Moreover, their 
loss, exposing the bone to the outer environment, favor its drying that promotes intravascular 
coagulation depriving the fracture of blood supply. Also, iatrogenic injuries, including vast 
surgical approach, wide periosteal stripping, excessive cauterization, or just brutal operative 
technique, superimpose traumatic changes impairing the healing.
Second of all, removal or drainage of hematoma or cellular infiltrates from the fracture, espe-
cially, when performed repeatedly, deprives it of molecular regulators [7].
Third of all, under hypoxia MSCs have been shown to differentiate into chondrocytes, instead of 
osteoblasts. This process, being natural at early stages of reparative processes, when prolongs, 
results in the formation of cartilaginous pseudoarthrosis. The problem usually occurs, when 
the fracture is immobilized inadequately or is not immobilized at all, as excessive movements 
between bone fragments disrupt newly formed vasculature depriving it of blood supply [39].
An especially unappreciated is the contribution of the shock in the cessation of fracture gap 
perfusion. Centralizing the circulation to protect the circulation of vital organs, it deprives the 
perfusion of peripheral tissues, including the fractured gap and surrounding it tissues [40]. 
When prolongs, shock aggravates tissue injury, impairs the healing, and increases the risk of 
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infection [41, 42]. An inadequate blood supply may also originate from central cardiovascu-
lar (stroke, cardiac arrest) insufficiency and peripheral vascular (i.e. atherosclerosis, venous 
thrombosis) diseases [43] (Figure 3).
Satisfactory healing requires an appropriate oxygenation and nutrition. Bone fracture corre-
sponds with the disruption of its vasculature leading to the necrosis of 5 to 10 mm-width bone 
fragments adjacent to the fracture gap [44]. The area of necrosis may spread on the damage 
of the neighboring soft tissues, cardiovascular insufficiency (decompensated heart failure, 
arterial damage, or occlusion, venous thrombosis), anemia, or infection [45, 46]. Hypothermia 
also exerts an impact on local circulation constricting blood vessels [47].
Figure 3. Oxygenation and nourishment of the fracture gap.
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Properly balanced diet provides all the nutrients, vitamins, and minerals that are necessary 
for healing. In case of bone fracture, an attention has to be paid over calcium, phosphates 
(osteoid formation), proteins (source of amino acids for collagen synthesis), and vitamin D3 
that may, in some cases, require supplementation.
Starvation is nowadays relatively seldom in developed societies, whose overweight and obese 
population alarmingly increases. Nevertheless, it could not be forgotten that it pertains only 
ca one-fourth of the Earth’s population, whereas the next three-fourth suffers from hun-
ger. Moreover, starvation and malnutrition may result from other than just a food shortage, 
reasons.
At the risk are especially elder, handicapped (also mentally) persons, drugs or alcohol abused, 
patients suffering from anorexia, and all others suffering from disturbed food intake, diges-
tion, absorption, or processing. Thus, at risk are all those suffering from various digestive dis-
orders, including short bowel syndrome, Hirschsprung’s or Crohn’s diseases, liver cirrhosis, 
pancreatitis and many others. Diabetes also leads to some type of starvation, as intracellular 
hypoglycemia deprives cells of glucose, the most important source of energy [48].
An increasing number of population implementing restrictive diet to reduce the body weight 
may present various nutritional deficiencies. Nevertheless, so far any religious (i.e. exclusion 
from the diet some kind of a meat) nor ideological (i.e. growing population of vegetarians and 
vegans) dietary restrictions nor customs were reported to influence bone healing. However, 
their negative insult, especially on young individuals, should be considered [49].
7.1. Habits disturbing healing of the fracture
Several habits affect the healing. Entering hundreds of detrimental substances, including 
highly toxic and carcinogenic ones, smoking impairs the function of progenitor cells, impairs 
local circulation, and reduces hemoglobin oxygenation disturbing reparative processes [50]. 
Alcohol was also shown to evoke its negative impact, but in small quantities may be beneficial 
supporting the fracture energetically and improving its perfusion [51, 52].
Several other addictions, including opioids, cannabinoids, and psychostimulants, indirectly 
influence the healing trajectories degrading the patient’s psychosomatic status, and thus resulting 
in poverty, homelessness, malnourishment, and increased susceptibility to infections and addi-
tional injuries. Addicted persons have also limited access to health services, both due to social 
and economic reasons, and their irrational behavior. Moreover, some of them are not interested 
in successful treatment at all, as complications, when occur ease them to obtain social support.
7.2. Mechanical aspects of fracture healing
Immobilization and stabilization of bone fragments after their anatomical repositioning pro-
vide an optimal mechanical environment for the healing. Thus, casts splints, and orthopedic 
implants are the most effective methods of treatment.
They provide an optimal, biomechanical environment to the fracture gap, as excessive inter-
fragmentary movements disrupt callus’ vasculature. Newly formed blood vessels, built with 
the single layer of endothelial cells only, are very fragile. Irrespective of the direction (by side, 
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angular, rotation or distraction), displacements disrupt the microvasculature that deprives the 
fracture of blood supply arresting the healing at the phase of cartilage ossification (Figure 4). 
In consequence, the cartilaginous pseudoarthrosis is formed presenting an abundant callus 
formation, the hypertrophic non-union [53]. It is usually observed in not immobilized frac-
tures, but may also occur in stabilized ones due to implant’s destruction (Figure 5).
However, rigid fixation precluding movements between bone fragments deprives them of 
mechanical stimuli that promote osteoblastogenesis [54]. Optimal amplitude of axial move-
ments is below 1 mm, as those are beneficial for osteogenesis, but do not disrupt the blood 
supply. Other dislocations are detrimental.
It was shown that an excessive distance between bone fragments leads to the cessation of 
reparative processes leading to non-union [55]. The contact between bone fragments is 
reduced by a half when translocation reaches 6% of the bone’s diameter or five degrees of 
angulation. Moreover, decreasing cortical thickness that characterizes osteoporotic bone 
aggravates the loss of interfragmentary contact (Figure 6a-c). That leads to the conclusion 
that fractures require accurate repositioning, especially osteoporotic ones [56].
Figure 4. Fracture gap and its newly formed vasculature (red lines; a) dislocated by-side (b), rotation (c), angulation (d) 
and controlled axial movements (e).
Figure 5. Hypertrophic non-union of the non-stabilized fracture.
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To enable healing, the maximal distance between bone fragments should not exceed 1 mm, 
although the minimal is the best (Figure 7). Compression, shortening the distance between 
bone fragments, is nowadays implemented under several treatment modalities including 
Figure 6. (a) An influence of by-side dislocations between bone fragments on bone contact. (b) An influence of angular 
dislocations between bone fragments on bone contact. (c) An influence of rotation between bone fragments on bone 
contact.
Figure 7. An inappropriate reduction of the fracture; Lack of the contact between bone fragments and screw situated 
in-between the fracture gap (arrows) disturb the healing.
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compression screws and plates, pre-bending of Arbeitsgemeinschaft für Osteosynthesefragen 
(AO) plates, intramedullary and external stabilizations and so on [57]. Moreover, it mechani-
cally stimulates osteogenesis (Figure 8).
Interposition of soft tissues or foreign material in-between bone fragments forms the barrier 
that precludes restoration of bone’s continuity (Figure 9).
Figure 8. Schematic representations showing the role of compression of the fracture gap in bone healing.
Figure 9. Disturbed healing due to an inadequate stabilization of the comminuted fracture of the left radius shaft in 26-years-
old male. The fracture (a1 and a2) was primarily stabilized with the interlocking plate (b1 and b2), but lack of the contact 
between one of its intermediate fragments precluded the healing. Moreover, mechanical stability was not obtained, as both 
proximal and distal fragments were stabilized practically with two screws only. The third and the fourth screws situated 
in-between the fracture gap, were mechanically inefficient and foreclosing the healing; the seventh’ was not screwed in at 
all (b3). Five months later, due to the lack of the progress of the healing (b), the fracture was revised, the fibrous scar was 
removed and marrow cavity was refreshed, bone fragments were reduced anatomically and stabilized with interlocking 
plate using four screws for each main fragment. Uneventful healing was observed on X-rays made on the 7th (c) and 12th 
(d) months after reoperation. Progressive healing (c3) and satisfactory remodeling (d3) were being observed.
Fracture Repair: Its Pathomechanism and Disturbances
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7.3. Pharmacotherapy
The negative impact of several pharmaceutics on healing processes was reported, including 
chemotherapeutics, antimicrobial drugs, steroids, heparins and antiresorptive drugs.
Chemotherapeutics are toxic to MSCs, reducing their number and activity and thus, depriv-
ing the fracture of osteoblastic progenitors. Their influence is aggravated by radiotherapy that 
is regularly used to treat neoplasms. Together with changed metabolism evoked by the tumor 
itself, those impair the healing.
Antibiotics were reported to affect the healing despite their beneficial capabilities to control 
infection. Tetracyclines were shown to impair ossification, thus arresting skeletal growth and 
fracture healing. Moreover, their negative impact prolongs for years, as bound with osteoid 
they impair bone remodeling decreasing its mechanical strength and thus, increase the risk of 
forthcoming fractures. Beta-lactams and cephalosporins, as well as ciprofloxacin, clindamy-
cin, rifampicin, macrolides, and many others, and also evoke their negative impact. Their 
usage is justified as far as the positive antimicrobial effect is rationalized, that is weighed 
against negative influence on the reparative processes [58].
Corticosteroids, used in asthma, rheumatoid and dermatologic diseases, demineralize skel-
eton resulting in steroid-induced osteoporosis. In consequence, increased susceptibility to 
fractures, but also their impaired healing and remodeling, occur. Moreover, their chronic 
use threatens the bone viability bringing the risk of steroid-induced osteonecrosis [59]. 
Nevertheless, those unwanted side effects could easily be controlled modifying the route of 
administration and reducing their doses [60]. Analogically, nonsteroidal, anti-inflammatory 
drugs (NSAIDs), widely used analgesics, disturb reparative processes, usually expressing 
their negative influence, when chronically used at high doses [51]. Antihistamines were also 
reported to affect the healing [61].
Heparins, regularly used in trauma surgery for antithrombotic prophylaxis, are known to 
bind several growth factors including TGF-β and BMPs, FGF and EGF, decreasing their bio-
availability for reparative processes [30]. Bisphosphonates, antiresorptive drugs dedicated for 
treatment of osteoporosis and prevention of fragility fractures, impair bone remodeling and 
healing, but also bring the risk of atypical fractures [62].
Other drugs were also shown to evoke negative impact on the bone union, including those used in 
the treatment of hypertension. Captopril, for instance, hinders angiogenesis and collagen deposi-
tion [63] and beta blockers affect wound healing through disturbed fibroblast proliferation [64].
7.4. Infection
Pathogens, colonizing the fracture gap, compete with its cells for nutrients, oxygen, and growth 
regulators depriving them of substances that are necessary for reparative processes. Moreover, 
hypoxia turns progenitor’s differentiation into chondroblastic cell lineage, and pathogen-asso-
ciated molecular patterns activate immune response aggravating the risk of non-union [65].
Unfortunately, eradication of microbes from the fracture gap is very hard, at least due to lim-
ited blood perfusion and poor antibiotic penetration. Moreover, they produce biofilms that 
protect them from recognition and counteraction by the immune system and antibiotics [66].
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8. Final remarks
Healing of the bone fracture is a biological process that proceeds due to the cooperation of 
various cell lineages under the control of the molecular regulators. Since, it bases on mecha-
nisms that were validated during skeletogenesis, everyone, who developed the skeleton 
properly, possess the mechanisms that enable him to heal the fracture. Thus, our role is just to 
provide optimal conditions for those natural mechanisms (Figure 10).
From the clinical point of view, an adequate supply of oxygen, nutrients, minerals, and 
vitamins under an appropriate biomechanical environment are the most important, as they 
enable those natural, biological mechanisms, to proceed uneventfully. Thus, fracture immo-
bilizations or stabilizations, rational nourishment, improving circulation and local blood 
perfusion, withholding smoking, reducing alcohol intake, and rationalizing pharmaceutical 
medication are among the most effective activities that improve the healing. Factors that posi-
tively and negatively affect it were discussed above giving the clear suggestions for effective 
treatment. Unfortunately, several of them could not be corrected or just are above our limits. 
Nevertheless, in the vast majority of cases, one can introduce the treatment that could reduce 
of the risk non-union.
Figure 10. Comminuted, multiple-level fractures of the right femur in 41-years-old male (femoral neck, trochanteric, and 
the shaft) anatomically reduced and stabilized operatively. The final result (36 months) showing satisfactory bone union 
at all fractures after implants removal.
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